← Back to Search

Manual aspiration for Pleural Effusion

N/A

Waitlist Available

Led By Roy Cho, MD

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately after removing the thoracentesis catheter

Awards & highlights

Study Summary

This trial will compare 3 methods of draining fluid from the chest during therapeutic thoracentesis. Patients will be randomly assigned to manual aspiration, vacuum bottle drainage, or wall suction methods. The primary outcome is the amount of time the procedure takes, with secondary outcomes of pain and dyspnea scores.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 hours post-procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 hours post-procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours post-procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pain and dyspnea scores- 24h post

Pain and dyspnea scores- 5m post

Pain and dyspnea scores- Baseline

+6 more

Trial Design

3Treatment groups

Active Control

Group I: Manual aspirationActive Control1 Intervention

pleural fluid is drained using a standard thoracentesis kit and via a syringe and three-way stopcock

Group II: Wall suctionActive Control1 Intervention

pleural fluid is drained using a standard thoracentesis kit and by attaching tubing to wall suctioning set at -50 mmHg continuously

Group III: Vacuum bottle drainageActive Control1 Intervention

pleural fluid is drained using a standard thoracentesis kit and tubing that attaches to a glass vacuum container

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,377 Previous Clinical Trials

1,588,194 Total Patients Enrolled

Roy Cho, MDPrincipal InvestigatorUniversity of Minnesota

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the sign-up process for this clinical trial still open?

"Evidently, this clinical trial has been made available for recruitment. It was posted on the 18th of January 2022 and most recently updated on 14th June of the same year according to information found at clinicaltrials.gov."

Answered by AI

What is the aggregate figure of participants enrolled in this clinical trial?

"Affirmative. According to clinicaltrials.gov, this medical trial is actively enrolling patients after being posted on January 18th 2022 and last updated June 14th 2022. The target recruitment size is 102 individuals from a single healthcare facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Thoracentesis QI Study

2022. "Thoracentesis QI Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05424120.